PHARMAC is pleased to announce the approval of an agreement with Bayer New Zealand Limited for the listing and supply of levonorgestrel 2 x 75 mg rods (Jadelle). This was the subject of a consultation letter dated 29 August 2014.

For more details, go to: http://www.pharmac.health.nz/news/notification-2014-09-26-jadelle/